A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation

Keyphrases

• Hematopoietic Stem Cell Transplantation 100%
• Myeloablative Therapy 100%
• Platelet Recovery 100%
• Stem Cell Transplantation 50%
• Clinical Variables 50%
• Hemorrhagic Disease 50%
• Platelet Transfusion 50%
• Clinical Outcomes 25%
• United States 25%
• Disease Pattern 25%
• Canada 25%
• Transplant Center 25%
• Platelet Count 25%
• Bone Marrow 25%
• CD34 25%
• Medical Records 25%
• Growth Factors 25%
• Radiation Therapy 25%
• Platelets 25%
• Grafting from 25%
• Multivariate Model 25%
• Fast Recovery 25%
• Fever 25%
• Clinical Laboratory 25%
• Allogeneic Bone Marrow Transplantation 25%
• Transfusion Burden 25%
• Autologous Peripheral Blood Stem Cells 25%
• HLA-matched Donor 25%
• Peripheral Blood Stem Cells 25%
• Delayed Recovery 25%
• 60-day Mortality 25%
• Clinical Strategies 25%
• Hepatic Veno-occlusive Disease 25%
• Post-transplant Growth 25%
• Healthcare Costs 25%
• Patient Quality of Life 25%
• Cost Per Patient 25%
• Accelerated Recovery 25%

Nursing and Health Professions

• Hematopoietic Stem Cell Transplantation 100%
• Platelet 100%
• Thrombocyte Transfusion 40%
• Clinical Outcome 20%
• Medical Record 20%
• Health Care Cost 20%
• Clinical Laboratory 20%
• Bone Marrow Transplantation 20%
• Stem Cell Therapy 20%
• Growth Factor 20%
• Platelet Count 20%
• Diseases 20%
• Radiotherapy 20%
• Quality of Life 20%
• Liver Vein Obstruction 20%
• Patient History of Stem Cell Transplantation 20%

Medicine and Dentistry

• Hematopoietic Stem Cell Transplantation 100%
• Platelet 100%
• Health Care Cost 50%
• Thrombocyte Transfusion 33%
• Peripheral Blood Stem Cell 33%
• Medical Record 16%
• Stem Cell Therapy 16%
• Growth Factor 16%
• Quality of Life 16%
• Observational Study 16%
• Patient History of Stem Cell Transplantation 16%
• Bone Marrow Transplantation 16%
• Hepatic Veno-Occlusive Disease 16%
• Diseases 16%
• Radiation Therapy 16%